Impact of an Optimized Omega-3 Formulation on Inflammation and Endothelial Dysfunction in Pulmonary Arterial Hypertension

NCT07697235 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Strasbourg, France